Zarski, Jean-Pierre

Determination of reliability criteria for liver stiffness evaluation by transient elastography

Boursier, J., Zarski, J.-P., de Ledinghen, V., Rousselet, M.-C., Sturm, N., Lebail, B., Fouchard-Hubert, I., Gallois, Y., Oberti, F., Bertrais, S., et al. (2013) · Hepatology

Liver Disease Diagnosis and TreatmentUltrasound Imaging and Elastography

Cited by 662

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Corpechot, C., Chazouillères, O., Rousseau, A., Le Gruyer, A., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2018) · New England Journal of Medicine

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 642

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival

Poynard, T., Naveau, S., Doffoel, M., Boudjema, K., Vanlemmens, C., Mantion, G., Messner, M., Launois, B., Samuel, D., Cherqui, D., et al. (1999) · Journal of Hepatology

Liver Disease and TransplantationOrgan Transplantation Techniques and Outcomes

Cited by 110

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort

Louvet, A., Bourcier, V., Archambeaud, I., d’Alteroche, L., Chaffaut, C., Oberti, F., Moreno, C., Roulot, D., Dao, T., Moirand, R., et al. (2023) · Journal of Hepatology

Alcohol Consumption and Health EffectsLiver Disease and Transplantation

Cited by 80

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Corpechot, C., Chazouillères, O., Rousseau, A., Guyader, D., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2017) · Journal of Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 45